FDA approves new drug Rasonque to treat advanced pancreatic cancer

The US FDA on Wednesday approved Revolution Medicines' Rasonque for advanced pancreatic cancer, opening a new treatment option for patients with metastatic disease. A large trial found the once-daily pill doubled survival rates, offering…

The significance of this report depends on the decisions, official reactions or confirmation that follow. The current assessment is initially based on reporting by France 24.

Readers should distinguish established facts from initial claims. Practical consequences will become clearer through responses from authorities, markets or independent sources.

Watch for official statements, independent confirmation of the key details and updates to the original report.